Jpmorgan Chase & CO Regeneron Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 7,059,371 shares of REGN stock, worth $4.94 Billion. This represents 0.41% of its overall portfolio holdings.

Number of Shares
7,059,371
Previous 7,489,500 5.74%
Holding current value
$4.94 Billion
Previous $7.87 Billion 36.13%
% of portfolio
0.41%
Previous 0.64%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$701.85 - $1046.91 $302 Million - $450 Million
-430,129 Reduced 5.74%
7,059,371 $5.03 Billion
Q3 2024

Dec 26, 2024
SELL
$1024.09 - $1201.76 $807 Million - $947 Million
-787,815 Reduced 9.52%
7,489,500 $7.87 Billion
Q3 2024

Nov 08, 2024
SELL
$1024.09 - $1201.76 $807 Million - $947 Million
-787,815 Reduced 9.52%
7,489,500 $7.87 Billion
Q2 2024

Dec 26, 2024
BUY
$883.2 - $1071.19 $696 Million - $844 Million
787,815 Added 10.52%
8,277,315 $8.7 Billion
Q2 2024

Aug 12, 2024
BUY
$883.2 - $1071.19 $486 Million - $589 Million
550,141 Added 7.12%
8,277,315 $8.7 Billion
Q1 2024

Dec 26, 2024
BUY
$902.69 - $993.35 $215 Million - $236 Million
237,674 Added 3.17%
7,727,174 $7.44 Billion
Q1 2024

May 10, 2024
BUY
$902.69 - $993.35 $452 Million - $497 Million
500,405 Added 6.92%
7,727,174 $7.44 Billion
Q4 2023

Dec 26, 2024
SELL
$775.18 - $881.7 $204 Million - $232 Million
-262,731 Reduced 3.51%
7,226,769 $6.35 Billion
Q4 2023

Feb 12, 2024
SELL
$775.18 - $881.7 $126 Million - $143 Million
-162,385 Reduced 2.2%
7,226,769 $6.35 Billion
Q3 2023

Nov 14, 2023
BUY
$692.45 - $844.37 $585 Million - $714 Million
845,167 Added 12.92%
7,389,154 $6.08 Billion
Q2 2023

Aug 11, 2023
BUY
$700.03 - $830.35 $140 Million - $166 Million
199,836 Added 3.15%
6,543,987 $4.7 Billion
Q1 2023

May 18, 2023
BUY
$680.49 - $826.97 $34.4 Million - $41.8 Million
50,600 Added 0.8%
6,344,151 $5.21 Billion
Q1 2023

May 11, 2023
BUY
$680.49 - $826.97 $125 Million - $152 Million
184,006 Added 3.01%
6,293,551 $5.17 Billion
Q4 2022

Feb 13, 2023
BUY
$705.89 - $766.39 $285 Million - $309 Million
403,676 Added 7.07%
6,109,545 $4.41 Billion
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $15.7 Million - $19.9 Million
27,437 Added 0.48%
5,705,869 $3.93 Billion
Q2 2022

Aug 11, 2022
BUY
$548.35 - $738.84 $391 Million - $527 Million
713,465 Added 14.37%
5,678,432 $3.36 Billion
Q1 2022

May 11, 2022
BUY
$595.12 - $698.43 $222 Million - $261 Million
373,438 Added 8.13%
4,964,967 $3.47 Billion
Q4 2021

Feb 10, 2022
BUY
$543.48 - $670.97 $266 Million - $328 Million
489,084 Added 11.92%
4,591,529 $2.9 Billion
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $2.35 Billion - $2.79 Billion
4,102,445 New
4,102,445 $2.48 Billion

Others Institutions Holding REGN

# of Institutions
1,487
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.43M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email